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This study examined whether altered joint angular motion during haptic exploration could account for a decline in haptic
sensitivity in individuals with PD by analyzing joint position data during haptic exploration of a curved contour. Each
participant’s hand was passively moved by a robotic arm along the edges of a virtual box (5 cm× 15 cm) with a curved left wall.
After each trial, participants indicated whether the contour was curved or straight. Visual, auditory, and tactile cues were
occluded, and an electrogoniometer recorded shoulder and elbow joint angles during each trial. The PD group in the OFF state
had a higher mean detection threshold (4.67m−1) than the control group (3.06m−1). Individuals with PD in the OFF state also
had a significantly greater magnitude of shoulder abduction than those in the ON state (p = 0 003) and a smaller magnitude of
elbow flexion than those in the ON state or compared to the control group (both p < 0 001). These findings suggest that
individuals with PD employ joint configurations that may contribute to haptic insensitivity. Dopamine replacement therapy
improved joint configurations during haptic exploration in patients with PD, suggesting a role for dopaminergic dysfunction in
PD-related haptic insensitivity.
1. Introduction
Parkinson’s disease (PD) has traditionally been characterized
as a movement disorder; however, PD is also associated with
perceptual deficits, such as decreased sensitivity of olfaction,
touch, proprioception, and haptic sensation [1–5]. These
deficits may be present in the early stages of the disease, such
that olfactory and somatosensory dysfunction have been
proposed as early markers of PD [2, 6, 7].
Haptic perception, also referred to as active touch [8], is
the ability to perceive the features of an object (e.g., shape,
size, and texture) through active touch. This perception
modality is the result of sensory and motor integration
combining tactile, proprioceptive, and motor signals. Haptic
perception is decreased in patients with mild-to-moderate
PD compared to that in healthy individuals [3]. Konczak
et al. [3] found that 82% of participants with PD exhibited
impaired perception of a virtual contour created by the
boundary forces of a robot manipulandum; in this study,
the median haptic threshold for the PD group was 343% that
of the healthy control group. A follow-up study showed that
dopamine replacement therapy (DRT) partially restored
haptic sensitivity in patients with PD [9], suggesting that
levodopa improves motor as well as perceptual function in
these patients.
Haptic exploration and kinesthesia rely on the appropri-
ate processing of proprioceptive information. Given that
patients with PD have prominent deficits in detecting and
integrating joint position andmovement [3, 10, 11], the ques-
tion arises whether deficits in haptic sensitivity result from
deficits in the processing of joint position information or
from an inability to properly integrate tactile and propriocep-
tive signals (i.e., a sensory integration deficit). Since PD is
typically characterized by motor deficits including the
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reduction of movement speed and amplitude [12], assess-
ments that use motor performance to measure propriocep-
tive acuity are not appropriate for evaluating this research
question [13]. Instead, we analyzed joint position during
haptic exploration of a curved contour before and after med-
ication in order to determine whether restricted or altered
joint motion during haptic exploration could account for
decreased haptic sensitivity in PD. We predicted that if
impaired haptic acuity was related to a motor deficit, there
would be characteristic changes in joint motion between
the ON and OFF medication states; in contrast, a lack of
altered joint motion behavior would suggest that impaired
haptic perception was related to a sensory integration deficit.
2. Method
2.1. Subjects. Six male patients with mild-to-moderate idio-
pathic PD (mean age, 66.3± 2.8 years; age range, 65–72
years; 4 right-handed patients with initial right-side disease
and 2 left-handed with initial left-side disease onset) and 6
age-matched male healthy control subjects who were free
of neurological disease and upper limb pathology (mean
age, 61.0± 10.4 years; age range, 46–72 years; all right-
handed) completed the study. Handedness was evaluated
using the Edinburgh Handedness Inventory [14]. All partic-
ipants provided written informed consent prior to study
participation. The study was approved by the Institutional
Review Board of the University of Minnesota.
Individuals with PD were recruited from the movement
disorder outpatient clinic at the University of Minnesota.
All 6 patients were diagnosed with late-onset (>40 years of
age) idiopathic PD. Prior to testing, all patients underwent
a clinical examination in which disease severity was rated
using the Unified Parkinson’s Disease Rating Scale (UPDRS)
[15]. All patients were evaluated once in the OFF medication
state (after a minimum 12-hour washout period) and once in
the ON medication state (at least 1.5 hours after taking their
routine antiparkinsonian medication[s] and obtaining a self-
reported optimal response), with both evaluations performed
by the same neurologist. Daily doses of medication were
standardized using an established formula [16] as follows:
100mg standard levodopa=125mg sustained-release levodo-
pa=1.5mg pramipexole =6mg ropinirole =10mg bromo-
criptine =1mg pergolide (levodopa equivalent values are
shown in Table 1). The inclusion criteria for both patients
with PD and healthy control subjects included a Mini-
Mental Status Examination (MMSE) score≥ 24 [17] and no
previous diagnoses of peripheral nerve disease or another
neurological condition. Demographics and clinical data are
provided in Table 1.
2.2. Apparatus and Procedure. The apparatus and procedure
have been described previously [9]. Briefly, participants
moved the handle of a 2-joint robotic manipulandum around
a predetermined shape bound by a virtual force field (Inter-
active Motion Technologies, InMotion2). The participant
sat facing the robot and holding the handle positioned at
the midline of the trunk, just below the shoulder joint. Vision
was occluded via opaque glasses, and a synthetic gauze glove
was worn to reduce friction between the skin of the hand and
the handle to minimize tactile cues (Figure 1(a)). All partici-
pants were instructed to gently hold the handle without
squeezing it or forcing it in any direction and to allow it to
move their hand around the space. Patients with PD used
the hand determined to be more affected by PD in the exam-
ination by a neurologist, and this hand was matched by
healthy control subjects. The participant’s hand was passively
moved by the manipulandum around the edges of a virtual
box (5 cm× 15 cm) with a curved left wall; the curvature of
the left side of the box was either convex or straight with cur-
vature values ranging from 0 to 7m−1. A curvature of 7m−1
translated to a 2.1 cm perpendicular deviation from the
straight path (Figure 1(b)). Contours were presented at inter-
vals of 0.5m−1, resulting in 15 different curvature values.
Using a forced-choice paradigm, participants were required
to indicate whether the trajectory was curved or straight at
the end of each trial. Data from the perceptual task have
previously been reported [9].
Two electrogoniometers (Biometrics Ltd., Cwmfelinfach,
UK) were used to measure arm joint angles during the experi-
mental task. A twin axis goniometer was attached across the
lateral aspect of the shoulder joint to measure shoulder
movement in the sagittal plane (shoulder flexion-extension)
and frontal plane (shoulder abduction-adduction). A single-
axis goniometerwasattachedacross theelbowjoint tomeasure
elbowflexion-extension.The goniometerswere connected to a
Biopac MP 36 system (Biopac Inc., Goleta, CA, USA), which
sampled goniometer data at a frequency of 120Hz.
The virtual curvature value, perceptual judgment of the
participant, and goniometer data were recorded for each trial.
Table 1: Clinical characteristics and basic demographics of patients with Parkinson’s disease.






MedicationTotal score Motor score
OFF ON OFF ON
1 72 M R 6 32 29 23 20 267 P
2 66 M R 6 40 25 27 12 500 L
3 65 M R 11 61 44 41 24 400 L
4 65 M L 2 41 27 29 15 1000 L
5 65 M L 9 29 23 18 12 350 L, P
6 65 M R 5 46 35 32 21 425 L, P
∗Handedness was based on the Edinburgh Handedness Inventory (range from 20 [R, right handed] to −20 [L, left handed]) [14]. L: levodopa; M: male;
P: pramipexole; UPDRS: Unified Parkinson’s Disease Rating Scale (range from 0 to 192, with higher scores indicating higher disease severity [15]).
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Each curvature value was tested 4 times. Healthy participants
completed 1 session that included 4 blocks of 15 trials each
for a total of 60 trials. Patients with PD completed 2 consec-
utive sessions for a total of 120 trials; the first session was
completed in the OFF state in the morning, and the second
session was subsequently completed in the ON state at least
1.5 hours after taking antiparkinsonian medication and
achieving an optimal response.
2.3. Data Analysis. The joint angles measured were shoulder
flexion (ShoFlex) and elbow flexion (ElbFlex) in the sagittal
plane and shoulder abduction (ShoAbd) in the frontal plane.
Shoulder angles (ShoFlex, ShoAbd) were calculated as the
angle between the vector joining the ipsilateral acromion to
the lateral epicondyle and the vector from the acromion pro-
cess towards the hip in the sagittal plane. Shoulder flexion
(ShoFlex) and shoulder abduction (ShoAbd) angles were cal-
culated from the same vectors in 2 different projected planes;
vectors were projected onto the sagittal plane to calculate the
angle of ShoFlex and onto the frontal plane to calculate the
angle of ShoAbd. The elbow angle (ElbFlex) was calculated
as the angle between the vector from the ipsilateral acromion
to the lateral epicondyle and a vector defined by the lateral
epicondyle and styloid process of the ulna. Goniometer data
were filtered offline with a 4th order low-pass Butterworth fil-
ter with a cutoff frequency of 1Hz. Subsequently, time series
data for each trial were cropped and the portion containing
curvature exploration was analyzed. A descriptive analysis
was performed on all 3 joint angle variables for each partici-
pant. Pearson’s correlation analyses were used to examine the
relationship between joint position and curvature values in
all groups and conditions. A multivariate analysis of variance
(MANOVA) was used to examine differences in joint angles
between groups. Steiger’s Z-test and Fisher’s Z transforma-
tion were used to examine differences in correlation coef-
ficients within groups and between groups, respectively
[18, 19]. The significance level was set to p < 0 05.
As presented previously [9], a psychometric sensitivity
function was calculated for each individual and group based
on participant responses. The detection threshold was
defined as the curvature value at the 75% correct response
level. The differences in thresholds between the PD and
control groups were analyzed using a one-way analysis of
variance. Pearson’s correlation analyses were used to exam-
ine the effects of medication dose and disease duration on
haptic sensitivity. Detailed descriptions of the analysis and
results for haptic sensitivity have been previously published
[9]. Findings from this component of the analysis are
presented only for comparison to the new data.
3. Results
3.1. Typical Joint Configuration during Haptic Exploration.
Individuals in both groups used shoulder flexion and elbow
extension to explore curvatures. Participants exhibited vari-
able temporal interjoint coordination patterns for shoulder
movement in the frontal plane. Some participants started
with shoulder abduction, moved towards adduction, and
stopped in an abducted shoulder position. Others showed
an opposite pattern beginning with shoulder adduction,
moving towards abduction, and stopping in an adducted
shoulder position. Due to the heterogeneity of the data, no
clear pattern could be established. Figure 2 shows a represen-
tative joint angle configuration derived from 3 subjects in
each group/condition.
3.2. Comparison of Joint Angles. Mean joint angles were cal-
culated within each group for each curvature. There were
no significant differences in the 15 curvature values for each
joint (p = 0 085) within each group. Accordingly, data were
collapsed across curvatures for each of the 3 joints (ElbFlex,
ShoAbd, and ShoFlex) in each group. Table 2 presents the
range and magnitudes of the 3 joint angles across 15 curva-
tures (60 trials in total for each participant) for each group.
The elbow joint had the greatest magnitude in all 3 groups.
There was a statistically significant between-group difference
in joint angle (F6,532 = 7 12, p < 0 001). A post hoc analysis
revealed that patients with PD had significantly greater mag-
nitudes of ShoAbd in the OFF state compared to the ON state
(p = 0 003) and smaller magnitudes of ElbFlex in the OFF
state compared to the ON state (p < 0 001). Magnitudes of
ShoFlex were significantly greater in patients with PD in the








Figure 1: Experimental setup. A robotic manipulandum was used to create a virtual space that was passively explored by the participants. (a)
Subjects wore goggles and gloves to occlude visual and tactile cues. (b) The participant’s hand was moved along a virtual box (15 cm× 5 cm)
that had a left side that was either curved or straight. The maximum curvature experienced by the participant translated to a 2.1 cm deviation
from a straight line.
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3.3. Group Detection Thresholds (Previously Reported). The
mean threshold was 3.06m−1 in the control group, 4.67m−1
in patients with PD in the OFF state, and 4.04m−1 in patients
with PD in the ON state. There was no significant correlation
between medication dose and detection threshold (PD-ON:
r = − 0 40; PD-OFF: r = 0 32) and between disease duration
and detection threshold (PD-ON: r = 0 33; PD-OFF:
r = 0 11). A detailed description of the data analysis and
results has been published previously [9].
3.4. Relationship between Joint Configuration and Haptic
Sensation. In order to examine the relationship between joint
angles and deviation from the straight line (curvature), we
transformed curvature values into perpendicular deviations
from the straight line in a time series and calculated Pearson’s
correlation coefficients; rShoAbd, rShoFlex, and rElbFlex
represent the correlation coefficients for deviation from the
straight line and the magnitude of each joint angle, respec-
tively. The mean correlation coefficients for each group are
presented in Table 3. Correlation coefficients were all nega-
tive values except for ShoFlex, indicating that participants
generally increased shoulder flexion, shoulder adduction,
and elbow extension to explore the curvature. Joint angles
and curvature values for the haptic exploration task were
modestly correlated (r = –0 33 to 0 28). For all 3 groups,
rElbFlex had the highest correlation coefficients and
rShoAbd had the lowest correlation coefficients among the
3 joint angles. Results from Fisher’s Z-test and Steiger’s Z-test
did not reveal statistically significant differences in correla-
tion coefficients between groups; however, results from Stei-
ger’s Z-test indicated that rShoAbd, rShoFlex, and rElbFlex
were all statistically different from one to the other within
each group (all p < 0 05).
4. Discussion
The main purpose of this study was to examine whether
restricted or altered joint motion could account for impaired
haptic sensitivity during contour exploration in patients with
PD. We found that the PD group in the ON state generally
used the same joint configurations and had similar levels of
haptic sensitivity compared to the healthy control group;
however, individuals with PD in the OFF state exhibited dif-
ferences in shoulder flexion compared to the those of the
healthy control group and differences in shoulder flexion

































































Figure 2: Representative shoulder abduction (a), shoulder flexion (b), and elbow flexion (c) angles derived from 3 patients in the PD group in
the ON and OFF states and 3 control participants.
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correlation coefficient for curvature and shoulder flexion was
increased, and haptic sensitivity was improved in patients
with PD after the administration of antiparkinsonian medi-
cation. Therefore, we suggest that altered joint positioning
at least partially accounts for decreased haptic sensitivity in
patients with PD.
Previous studies have reported that the central nervous
system (CNS) is more accurate in processing end-point con-
trol variables than joint excursion variables for kinesthetic-
related movements [20, 21]. Mechanoreceptors relay infor-
mation related to kinesthesia to the CNS; therefore, appropri-
ate joint configurations should facilitate accurate haptic
perception during motor tasks. Yet, it is unclear whether
joints differentially contribute to haptic sensation in move-
ments involving multiple joints. Scott and Loeb and Tripp
et al. suggested that proximal joint positions primarily con-
tribute to end-point position judgments based on computa-
tional models [22, 23]. McCloskey et al. reported that
proximal joints had greater kinesthetic sensitivity than distal
joints; furthermore, proximal joints were more sensitive to
joint position and distal joints were better for determining
end-point positions [24]. In our study, participants generally
used shoulder flexion and elbow extension during the haptic
exploration task. Healthy control subjects showed the smal-
lest shoulder range of motion (ROM) in the sagittal plane
and the largest elbow ROM. Our data are therefore consistent
with the hypothesis that joints function differentially for the
generation of perceptual judgments depending on the
requirements of the specific motor task.
Galloway and Koshland argued that most multijoint
movements of the upper extremities have a shoulder-
centered pattern. That is, the shoulder ROM is typically dou-
ble that of the elbow. If the shoulder ROM is less than half of
the elbow ROM and the hand path is straight, the shoulder-
centered pattern switches to an elbow-centered pattern
[25]. Our findings revealed an average shoulder ROM of less
than half the elbow ROM in the control and PD-ON groups;
however, the hand path was curved during haptic explora-
tion. We therefore suggest that the task in this study pro-
duced a shoulder-centered movement pattern; that is,
shoulder acceleration was mainly due to shoulder muscle
torque, whereas elbow and wrist acceleration were deter-
mined by a combination of muscle torque and significant
interaction torque for haptic exploration. Accordingly, the
shoulder joint was likely a major contributor to haptic sensa-
tion in healthy control subjects and in the PD-ON group.
Previous research has indicated that the CNS uses kines-
thetic information from the biarticular muscles during multi-
joint movements; however, the biarticular muscles generally
provide more ambiguous information about limb position
and movement than that of the monoarticular muscles [26].
Therefore, the CNS may rely on inputs from the monoarticu-
lar muscles as well as cutaneous receptors and joint receptors
to resolve ambiguities in kinesthetic information from the
biarticular muscles. At the same time, the CNS derives
more information from the extent of muscle stretch during
overall movement than from any single joint [26]. Taken
together, it can be argued that the CNS uses internal rep-
resentations to integrate sensory inputs for the formation
of haptic perception [27].
The current findings are consistent with previous
research indicating impaired multijoint coordination and
the decomposition of movement in patients with PD [28].
Instead of integrating kinesthetic inputs from the shoulder
and elbow joints, patients with PD tend to rely on sensory
inputs from a single joint and lack the ability to weight sen-
sory information from different joints to judge limb position
and movement [26]. We also found that patients with PD in
the OFF state mainly relied on sensory inputs from a single
joint during haptic exploration, as there was a larger correla-
tion coefficient for the relationship between elbow flexion
and curvature than between shoulder flexion and curvature.
In contrast, the healthy control group utilized information
from both the shoulder and elbow joints. Therefore, abnor-
mal joint configurations might underlie to impaired haptic
sensitivity in PD.
A neuroimaging study of sensory-evoked brain activation
after application of a vibratory stimulus to the right index fin-
ger found that patients with PD had insufficient activation in
several brain regions contralateral to the side of vibratory
stimulus presentation and compensatory hyperactivation
on the side ipsilateral to stimulus presentation compared to
healthy control subjects [29]. The haptic exploration of
Table 3: Correlation coefficients between curvature values and joint
angles in each group.
Correlation coefficient (r)
Control PD-ON PD-OFF
rShoAbd 0.04± 0.21 −0.12± 0.32 −0.13± 0.29
rShoFlex 0.28± 0.16 0.27± 0.17 0.17± 0.23
rElbFlex −0.30± 0.10 −0.29± 0.09 −0.33± 0.11
Note: there were significant differences (p < 0 05) between each correlation
coefficient within each group. ElbFlex: elbow flexion; PD-OFF: Parkinson’s
disease in the OFF state; PD-ON: Parkinson’s disease in the ON state;
ShoAbd: shoulder abduction; ShoFlex: shoulder flexion.
Table 2: Range and magnitude of joint angles in each group.
Group Control PD-ON PD-OFF p
ShoAbd
Min −12.64° −37.57° −37.70°
Max 77.52° 50.68° 71.57°
ROM 5.34± 4.12°AB 4.40± 2.62°A 6.60± 5.65°B 0.005∗
ShoFlex
Min 16.85° 19.67° −1.76°
Max 49.70° 76.41° 67.44°
ROM 3.81± 1.34°A 4.36± 1.15°B 4.02± 2.10°AB 0.08
ElbFlex
Min 39.83° 27.39° 6.85°
Max 89.61° 88.36° 89.5°
ROM 16.20± 2.65°A 15.26± 3.16°A 12.43± 5.88°B <0.001∗
∗p < 0 05
Note: the same letter indicates nonsignificant effect. A different letter indicates
a significant difference. ElbFlex: elbow flexion; PD-OFF: Parkinson’s disease in
the OFF state; PD-ON: Parkinson’s disease in the ON state; ROM: range of
motion; ShoAbd: shoulder abduction; ShoFlex: shoulder flexion.
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curvature is based on somatosensory information about the
motions and forces experienced during movement. This
information is primarily derived from proprioceptive recep-
tors, cutaneous receptors, and mechanoreceptors. A previous
study concluded that the perception of actual hand path is
mainly derived from proprioceptive feedback rather than
force feedback [30], suggesting that haptic perception is gen-
erated from the integration of proprioceptive information
across several joints and the integration of proprioceptive
and tactile information from the fingers and palm. To this
end, several studies have provided strong evidence that dys-
function of the cerebro-basal-ganglia loop affects the ability
to detect arm position and movement [5, 31–34]. In support
of this idea, evidence from animal studies has demonstrated
that the depletion of striatal dopamine leads to the inability
to use sensory information for motor performance [35].
Other animal studies have shown that basal ganglia neurons,
mainly located in the internal globus pallidus, have receptive
fields for proprioceptive signals for the processing of both
passive and active joint motions [36–38]. In a single-cell
recording study of patients with PD undergoing neurosur-
gery, it was reported that 1/3 of neurons in the nucleus
subthalamicus responded to both passive and active move-
ments [39]. Therefore, we speculate that basal ganglia
dysfunction was primarily responsible for higher haptic
thresholds observed in patients with PD in the OFF state
[40]. Moreover, it is possible that DRT produced compensa-
tory changes in PD-related basal ganglia deficits to improve
joint and directional specificity. We thus postulate that DRT
enhanced neurotransmission in the thalamo-cortico-basal
ganglia loop [41] to elicit changes in joint configuration dur-
ing haptic exploration, resulting in similar patterns of joint
angles and lowered haptic thresholds in the PD-ON group.
Previous studies have reported that DRT may actually
cause the deterioration of proprioceptive function in PD
[11, 42] by producing deficits in proprioceptive processing.
Detection thresholds were not statistically different between
the PD-ON and PD-OFF states in the current study; there-
fore, our results suggest that DRT did not have a detrimental
effect on proprioception. Inconsistencies between our study
and previous studies may have been related to different
demographic characteristics of the included PD cohorts.
For example, O’Suilleabhain et al. [11] recruited individuals
with PD who were approximately 40 years of age, which
suggests that patients had early-onset PD and/or an atypical
presentation of PD. In contrast, our study examined patients
ages of 50–65 years with late-onset PD. Furthermore, differ-
ent studies have used different experimental protocols for
testing in the ON and OFF medication states. O’Suilleabhain
et al. [11] retested patients 1 hour after medication, Mongeon
et al. [42] retested patients 1-2 hours after medication, and
we retested patients 1.5 hours after medication with the addi-
tional requirement of a self-reported optimal response.
Although all studies administered the UPDRS after medica-
tion to ensure efficacy, different time intervals between
administration and testing may underlie inconsistent find-
ings between studies. Finally, previous studies used experi-
mental tasks that required participants to memorize a target
or joint position for perceptual judgments, which made it
difficult to determine whether observed impairments were
related to perception or memory. In the current study, we
used a passive motion task to exclude the potential influ-
ence of motor and memory impairments on perceptual
judgments. Thus, the current findings provide an impor-
tant and unique insight into haptic insensitivity in patients
with PD.
5. Limitations
The present study had several limitations. First, the power
of our statistical analyses was limited by a small sample
size. Second, all participants were male, which may limit
the generalizability of our findings. Although there is no
clear evidence that sex has an effect on haptic sensitivity
or joint configuration, potential sex differences should be
examined in future studies. Finally, the experimental proto-
col did not include any functional tasks to directly correlate
activity performance with haptic sensitivity. This further
limits the generalizability of the current findings to only the
tested task. Future research should incorporate functional
tasks to examine the contribution of haptic sensitivity to
daily activities.
6. Conclusions
The findings of the current study suggest that patients with
PD employ abnormal joint configurations that contribute to
haptic insensitivity. DRT may enhance the neurotransmis-
sion in the thalamo-cortico-basal ganglia loop to improve
motor ability in patients with PD, resulting in the use of cor-
rect joint configurations during haptic exploration and thus
increased haptic sensitivity.
Conflicts of Interest
The authors declare that they have no competing interests.
Acknowledgments
This project was supported in part by the Healthy Aging
Research Center (EMRPD1G0241), Chang Gung Memorial
Hospital (BMRPC58), the National Sciences Council
(NSC102-2314-B-182-009-MY3), and theMinistry of Science
and Technology (MOST105-2314-B-182-011) in Taiwan.
References
[1] S. G. Diamond, J. S. Schneider, and C. H. Markham, “Oral sen-
sorimotor defects in patients with Parkinson’s disease,”
Advances in Neurology, vol. 45, pp. 335–338, 1987.
[2] B. Herting, S. Schulze, H. Reichmann, A. Haehner, and T.
Hummel, “A longitudinal study of olfactory function in
patients with idiopathic Parkinson’s disease,” Journal of
Neurology, vol. 255, no. 3, pp. 367–370, 2008.
[3] J. Konczak, K. Y. Li, P. J. Tuite, and H. Poizner, “Haptic per-
ception of object curvature in Parkinson’s disease,” PloS One,
vol. 3, no. 7, article e2625, 2008.
[4] R. I. Mesholam, P. J. Moberg, R. N. Mahr, and R. L. Doty,
“Olfaction in neurodegenerative disease: a meta-analysis of
6 Behavioural Neurology
olfactory functioning in Alzheimer’s and Parkinson’s dis-
eases,” Archives of Neurology, vol. 55, no. 1, pp. 84–90,
1998.
[5] S. Zia, F. Cody, and D. O'Boyle, “Joint position sense is
impaired by Parkinson’s disease,” Annals of Neurology,
vol. 47, no. 2, pp. 218–228, 2000.
[6] J. Konczak, K. Krawczewski, P. Tuite, and M. Maschke, “The
perception of passive motion in Parkinson’s disease,” Journal
of Neurology, vol. 254, no. 5, pp. 655–663, 2007.
[7] M. Maschke, C. M. Gomez, P. J. Tuite, and J. Konczak,
“Dysfunction of the basal ganglia, but not the cerebellum,
impairs kinaesthesia,” Brain, vol. 126, no. Pt 10, pp. 2312–
2322, 2003.
[8] J. G. James, The Senses Considered as Perceptual System,
Houghton Mufflin, Boston, 1966.
[9] K. Y. Li, K. Pickett, I. Nestrasil, P. Tuite, and J. Konczak, “The
effect of dopamine replacement therapy on haptic sensitivity
in Parkinson’s disease,” Journal of Neurology, vol. 257,
no. 12, pp. 1992–1998, 2010.
[10] S. V. Adamovich, M. B. Berkinblit, W. Hening, J. Sage, and
H. Poizner, “The interaction of visual and proprioceptive
inputs in pointing to actual and remembered targets in Par-
kinson’s disease,” Neuroscience, vol. 104, no. 4, pp. 1027–
1041, 2001.
[11] P. O'Suilleabhain, J. Bullard, and R. B. Dewey, “Proprioception
in Parkinson’s disease is acutely depressed by dopaminergic
medications,” Journal of Neurology, Neurosurgery, and Psychi-
atry, vol. 71, no. 5, pp. 607–610, 2001.
[12] A. Samii, J. G. Nutt, and B. R. Ransom, “Parkinson’s disease,”
Lancet, vol. 363, no. 9423, pp. 1783–1793, 2004.
[13] K. Y. Li, W. J. Su, H. W. Fu, and K. A. Pickett, “Kinesthetic
deficit in children with developmental coordination disorder,”
Research in Developmental Disabilities, vol. 38, pp. 125–133,
2015.
[14] R. C. Oldfield, “The assessment and analysis of handedness:
the Edinburgh inventory,” Neuropsychologia, vol. 9, no. 1,
pp. 97–113, 1971.
[15] S. E. Fahn and R. Elton, “Members of the UPDRS development
committee,” in Recent Development in Parkinson's Disease.
Volume 2, S. Fahn CDM, P. Jenner and P. Teychenne, Eds.,
pp. 153–163, Macmillan Health Care Information, Florham
Park, NJ, 1987, 293-304.
[16] S. Fahn, “Parkinson disease, the effect of levodopa, and the
ELLDOPA trial. Earlier vs later L-DOPA,” Archives of Neurol-
ogy, vol. 56, no. 5, pp. 529–535, 1999.
[17] M. F. Folstein, S. E. Folstein, and P. R. McHugh, ““Mini-men-
tal state”. A practical method for grading the cognitive state of
patients for the clinician,” Journal of Psychiatric Research,
vol. 12, no. 3, pp. 189–198, 1975.
[18] J. H. Steiger, “Tests for comparing elements of a correlation
matrix,” Psychological Bulletin, vol. 87, no. 2, pp. 245–251, 1980.
[19] R. A. Fisher, “Frequency distribution of the values of the
correlation coefficient in samples from an indefinitely large
population,” Biometrika, vol. 10, no. 4, pp. 507–521, 1915.
[20] L. Bevan, P. Cordo, L. Carlton, andM. Carlton, “Proprioceptive
coordination of movement sequences: discrimination of joint
angle versus angular distance,” Journal of Neurophysiology,
vol. 71, no. 5, pp. 1862–1872, 1994.
[21] C. T. Fuentes and A. J. Bastian, “Where is your arm? Varia-
tions in proprioception across space and tasks,” Journal of
Neurophysiology, vol. 103, no. 1, pp. 164–171, 2010.
[22] S. H. Scott and G. E. Loeb, “The computation of position sense
from spindles in mono- and multiarticular muscles,” The
Journal of Neuroscience, vol. 14, no. 12, pp. 7529–7540, 1994.
[23] B. L. Tripp, T. L. Uhl, C. G. Mattacola, C. Srinivasan, and R.
Shapiro, “A comparison of individual joint contributions to
multijoint position reproduction acuity in overhead-
throwing athletes,” Clinical Biomechanics (Bristol, Avon),
vol. 21, no. 5, pp. 466–473, 2006.
[24] D. I. McCloskey, “Detection and execution of movements,”
Psychological Research, vol. 55, no. 2, pp. 139–143, 1993.
[25] J. C. Galloway and G. F. Koshland, “General coordination of
shoulder, elbow and wrist dynamics during multijoint arm
movements,” Experimental Brain Research, vol. 142, no. 2,
pp. 163–180, 2002.
[26] D. L. Sturnieks, J. R. Wright, and R. C. Fitzpatrick, “Detection
of simultaneous movement at two human arm joints,” The
Journal of Physiology, vol. 585, no. Pt 3, pp. 833–842, 2007.
[27] J. Schwoebel and H. B. Coslett, “Evidence for multiple, distinct
representations of the human body,” Journal of Cognitive Neu-
roscience, vol. 17, no. 4, pp. 543–553, 2005.
[28] R. D. Seidler, J. L. Alberts, and G. E. Stelmach, “Multijoint
movement control in Parkinson’s disease,” Experimental Brain
Research, vol. 140, no. 3, pp. 335–344, 2001.
[29] H. Boecker, A. Ceballos-Baumann, P. Bartenstein et al., “Sen-
sory processing in Parkinson’s and Huntington’s disease:
investigations with 3DH(2)(15)O-PET,” Brain, vol. 122, no. Pt
9, pp. 1651–1665, 1999.
[30] W. Song, M. Flanders, and J. F. Soechting, “Effect of compli-
ance on haptic perception of curvature,” Somatosensory &
Motor Research, vol. 21, no. 3-4, pp. 177–182, 2004.
[31] N. L. Keijsers, M. A. Admiraal, A. R. Cools, B. R. Bloem, and C.
C. Gielen, “Differential progression of proprioceptive and
visual information processing deficits in Parkinson’s disease,”
The European Journal of Neuroscience, vol. 21, no. 1,
pp. 239–248, 2005.
[32] E. Khudados, F. W. Cody, and D. J. O'Boyle, “Proprioceptive
regulation of voluntary ankle movements, demonstrated using
muscle vibration, is impaired by Parkinson’s disease,” Journal
of Neurology, Neurosurgery, and Psychiatry, vol. 67, no. 4,
pp. 504–510, 1999.
[33] J. S. Schneider, S. G. Diamond, and C. H. Markham, “Deficits
in orofacial sensorimotor function in Parkinson’s disease,”
Annals of Neurology, vol. 19, no. 3, pp. 275–282, 1986.
[34] E. E. Jobst, M. E. Melnick, N. N. Byl, G. A. Dowling, and M. J.
Aminoff, “Sensory perception in Parkinson disease,” Archives
of Neurology, vol. 54, no. 4, pp. 450–454, 1997.
[35] J. M. Henderson, S. Watson, G. M. Halliday, T. Heinemann,
and M. Gerlach, “Relationships between various behavioural
abnormalities and nigrostriatal dopamine depletion in the uni-
lateral 6-OHDA-lesioned rat,” Behavioural Brain Research,
vol. 139, no. 1-2, pp. 105–113, 2003.
[36] M. D. Crutcher and M. R. DeLong, “Single cell studies of the
primate putamen. I. Functional organization,” Experimental
Brain Research, vol. 53, no. 2, pp. 233–243, 1984.
[37] M. D. Crutcher and M. R. DeLong, “Single cell studies of the
primate putamen. II. Relations to direction of movement and
pattern of muscular activity,” Experimental Brain Research,
vol. 53, no. 2, pp. 244–258, 1984.
[38] M. R. DeLong, M. D. Crutcher, and A. P. Georgopoulos,
“Primate globus pallidus and subthalamic nucleus: functional
7Behavioural Neurology
organization,” Journal of Neurophysiology, vol. 53, no. 2,
pp. 530–543, 1985.
[39] M. C. Rodriguez-Oroz, M. Rodriguez, J. Guridi et al., “The
subthalamic nucleus in Parkinson’s disease: somatotopic
organization and physiological characteristics,” Brain,
vol. 124, no. Pt 9, pp. 1777–1790, 2001.
[40] J. L. Contreras-Vidal and D. R. Gold, “Dynamic estimation of
hand position is abnormal in Parkinson’s disease,” Parkinson-
ism & Related Disorders, vol. 10, no. 8, pp. 501–506, 2004.
[41] B. G. Clissold, C. D. McColl, K. R. Reardon, M. Shiff, and P. A.
Kempster, “Longitudinal study of the motor response to
levodopa in Parkinson’s disease,” Movement Disorders,
vol. 21, no. 12, pp. 2116–2121, 2006.
[42] D. Mongeon, P. Blanchet, and J. Messier, “Impact of Parkin-
son’s disease and dopaminergic medication on proprioceptive
processing,” Neuroscience, vol. 158, no. 2, pp. 426–440, 2009.
8 Behavioural Neurology



















































 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
